About
Platform
Products
bCap 1
eCap 1
Lab
Team
Partnering & Licensing
Careers
Openings
News
Contact
Dyno advances AI-powered gene therapy
Novartis and Sarepta tap Dyno Therapeutics to use machine learning for gene therapy
Spun out of George Church’s lab, this biotech upstart is mapping the AAV universe for Novartis, Sarepta to gaze
Novartis, Sarepta join Dyno’s enterprise to boldly go to new gene therapy frontier
Accurately quantifying transduction within barcoded AAV capsid libraries via tracking of single-molecule ID tags
Dyno Therapeutics launches to improve viral vectors for gene therapy
Dyno to scale the heights of AAV vector engineering
AAV Optimization on the Fast-Track Hopes to Advance Gene Therapies
George Church lab spin-off Dyno Therapeutics to use machine learning for gene therapy
Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design
